Mind Medicine (MindMed) Inc. (MNMD)

2d ago, source: Yahoo Finance

NEW YORK, May 09, 2024--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain ...

Mind Medicine (MindMed) Inc. (MNMD) Q1 2024 Earnings Call Transcript

9d ago, source: Seeking Alpha

Good day, and thank you for standing by. Welcome to the MindMed Q1 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there ...

MindMed Reports First Quarter 2024 Financial Results and Business Updates

9d ago, source: Stockhouse

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today ...

MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update

16d ago, source: Joplin Globe

(NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it plans to host a ...

MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York

13d ago, source: Business Wire

Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product ...

MindMed to Present at Upcoming May Medical Conferences

23d ago, source: ADVFN

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders ...

MindMed Reports First Quarter 2024 Financial Results and Business Updates

10d ago, source: Eagle-Tribune

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today ...

Mind Medicine (MindMed) Inc.

24d ago, source: Wall Street Journal

1 Day MNMD 2.19% DJIA 0.69% Russell 2K 1.79% Health Care/Life Sciences 0.59% ...

MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update

15d ago, source: The Bakersfield Californian

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders ...

Mind Medicine (MindMed) Inc. (MNMD)

9d ago, source: Yahoo Finance

NEW YORK, May 09, 2024--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health ...